Authors:
PRATESI G
DECESARE M
CASERINI C
PEREGO P
DALBO L
POLIZZI D
SUPINO R
BIGIONI M
MANZINI S
IAFRATE E
SALVATORE C
CASAZZA A
ARCAMONE F
ZUNINO F
Citation: G. Pratesi et al., IMPROVED EFFICACY AND ENLARGED SPECTRUM OF ACTIVITY OF A NOVEL ANTHRACYCLINE DISACCHARIDE ANALOG OF DOXORUBICIN AGAINST HUMAN TUMOR XENOGRAFTS, Clinical cancer research, 4(11), 1998, pp. 2833-2839
Citation: G. Pratesi et al., CORRESPONDENCE RE - CASERINI,C. ET-AL., APOPTOSIS AS A DETERMINANT OFTUMOR SENSITIVITY TO TOPOTECAN IN HUMAN OVARIAN-TUMORS - PRECLINICAL IN VITROLIN VIVO STUDIES - REPLY, Clinical cancer research, 4(1), 1998, pp. 262-262
Citation: G. Pratesi et al., CORRESPONDENCE RE - CASERINI,C. ET-AL., APOPTOSIS AS A DETERMINANT OFTUMOR SENSITIVITY TO TOPOTECAN IN HUMAN OVARIAN-TUMORS - PRECLINICAL IN VITROLIN VIVO STUDIES - REPLY, Clinical cancer research, 4(1), 1998, pp. 262-262
Authors:
PEREGO P
ROMANELLI S
CARENINI N
MAGNANI I
LEONE R
BONETTI A
PAOLICCHI A
ZUNINO F
Citation: P. Perego et al., OVARIAN-CANCER CISPLATIN-RESISTANT CELL-LINES - MULTIPLE CHANGES INCLUDING COLLATERAL SENSITIVITY TO TAXOL, Annals of oncology, 9(4), 1998, pp. 423-430
Authors:
PEREGO P
ZUNINO F
CARENINI N
GIULIANI F
SPINELLI S
HOWELL SB
Citation: P. Perego et al., REGULATION OF SENSITIVITY TO CISPLATIN AND PLATINUM-CONTAINING DRUGS BY REPAIR AND CHECKPOINT CONTROL GENES IN SCHIZOSACCHAROMYCES-POMBE, Annals of oncology, 9, 1998, pp. 517-517
Authors:
ROMANELLI S
PEREGO P
PRATESI G
CARENINI N
TORTORETO M
ZUNINO F
Citation: S. Romanelli et al., IN-VITRO AND IN-VIVO INTERACTION BETWEEN CISPLATIN AND TOPOTECAN IN OVARIAN-CARCINOMA SYSTEMS, Cancer chemotherapy and pharmacology, 41(5), 1998, pp. 385-390
Citation: P. Perego et al., EXPERIMENTAL-STUDY OF HYDROGEN KINETICS FROM AGROINDUSTRIAL BY-PRODUCT - OPTIMAL CONDITIONS FOR PRODUCTION AND FUEL-CELL FEEDING, Bioprocess engineering, 19(3), 1998, pp. 205-211
Authors:
PEREGO P
ZUNINO F
CARENINI N
GIULIANI F
SPINELLI S
HOWELL SB
Citation: P. Perego et al., SENSITIVITY TO CISPLATIN AND PLATINUM-CONTAINING COMPOUNDS OF SCHIZOSACCHAROMYCES-POMBE RAD MUTANTS, Molecular pharmacology, 54(1), 1998, pp. 213-219
Authors:
LANZI C
PEREGO P
SUPINO R
ROMANELLI S
PENSA T
CARENINI N
VIANO I
COLANGELO D
LEONE R
APOSTOLI P
CASSINELLI G
GAMBETTA RA
ZUNINO F
Citation: C. Lanzi et al., DECREASED DRUG ACCUMULATION AND INCREASED TOLERANCE TO DNA-DAMAGE IN TUMOR-CELLS WITH A LOW-LEVEL OF CISPLATIN RESISTANCE, Biochemical pharmacology, 55(8), 1998, pp. 1247-1254
Authors:
PEREGO P
RIGHETTI SC
SUPINO R
DELIA D
CASERINI C
CARENINI N
BEDOGNE B
BROOME E
KRAJEWSKI S
REED JC
ZUNINO F
Citation: P. Perego et al., ROLE OF APOPTOSIS AND APOPTOSIS-RELATED PROTEINS IN THE CISPLATIN-RESISTANT PHENOTYPE OF HUMAN TUMOR-CELL LINES, Apoptosis, 2(6), 1997, pp. 540-548
Authors:
CASERINI C
PRATESI G
TORTORETO M
BEDOGNE B
CARENINI N
SUPINO R
PEREGO P
RIGHETTI SC
ZUNINO F
Citation: C. Caserini et al., APOPTOSIS AS A DETERMINANT OF TUMOR SENSITIVITY TO TOPOTECAN IN HUMANOVARIAN-TUMORS - PRECLINICAL IN-VITRO IN-VIVO STUDIES, Clinical cancer research, 3(6), 1997, pp. 955-961
Authors:
LISSONI A
CORMIO G
PEREGO P
GABRIELE A
CANTU MG
BRATINA G
Citation: A. Lissoni et al., CONSERVATIVE MANAGEMENT OF ENDOMETRIAL STROMAL SARCOMA IN YOUNG-WOMEN, International journal of gynecological cancer, 7(5), 1997, pp. 364-367
Citation: P. Perego et al., MICROBIOLOGICAL CORROSION IN AEROBIC AND ANAEROBIC WASTE PURIFICATIONPLANTS - SAFETY AND EFFICIENCY PROBLEMS, Bioprocess engineering, 17(2), 1997, pp. 103-109
Citation: F. Zunino et al., ROLE OF APOPTOTIC RESPONSE IN CELLULAR-RESISTANCE TO CYTOTOXIC AGENTS, Pharmacology & therapeutics, 76(1-3), 1997, pp. 177-185
Authors:
LANDONI F
MANEO A
COLOMBO A
PLACA F
MILANI R
PEREGO P
FAVINI G
FERRI L
MANGIONI C
Citation: F. Landoni et al., RANDOMIZED STUDY OF RADICAL SURGERY VERSUS RADIOTHERAPY FOR STAGE IB-IIA CERVICAL-CANCER, Lancet, 350(9077), 1997, pp. 535-540
Authors:
ZANETTA G
LISSONI A
GABRIELE A
LANDONI F
COLOMBO A
PEREGO P
MANGIONI C
Citation: G. Zanetta et al., INTENSE NEOADJUVANT CHEMOTHERAPY WITH CISPLATIN AND EPIRUBICIN FOR ADVANCED OR BULKY CERVICAL AND VAGINAL ADENOCARCINOMA, Gynecologic oncology, 64(3), 1997, pp. 431-435
Citation: P. Perego et Sb. Howell, MOLECULAR MECHANISMS CONTROLLING SENSITIVITY TO TOXIC METAL-IONS IN YEAST, Toxicology and applied pharmacology, 147(2), 1997, pp. 312-318
Citation: P. Perego et al., ROLE OF DETERMINANTS OF CADMIUM SENSITIVITY IN THE TOLERANCE OF SCHIZOSACCHAROMYCES-POMBE TO CISPLATIN, Molecular pharmacology, 51(1), 1997, pp. 12-18
Authors:
PEREGO P
PAOLICCHI A
TONGIANI R
POMPELLA A
TONARELLI P
CARENINI N
ROMANELLI S
ZUNINO F
Citation: P. Perego et al., THE CELL-SPECIFIC ANTIPROLIFERATIVE EFFECT OF REDUCED GLUTATHIONE IS MEDIATED BY GAMMA-GLUTAMYL TRANSPEPTIDASE-DEPENDENT EXTRACELLULAR PROOXIDANT REACTIONS, International journal of cancer, 71(2), 1997, pp. 246-250
Authors:
OTTONE F
MIOTTI S
BOTTINI C
BAGNOLI M
PEREGO P
COLNAGHI MI
MENARD S
Citation: F. Ottone et al., RELATIONSHIP BETWEEN FOLATE-BINDING PROTEIN EXPRESSION AND CISPLATIN SENSITIVITY IN OVARIAN-CARCINOMA CELL-LINES, British Journal of Cancer, 76(1), 1997, pp. 77-82
Citation: C. Pagella et al., BIOTECHNOLOGICAL H2S GAS TREATMENT WITH THIOBACILLUS-FERROOXIDANS, Chemical engineering & technology, 19(1), 1996, pp. 79-88
Citation: P. Perego et al., ISOLATION AND CHARACTERIZATION OF A CISPLATIN-RESISTANT STRAIN OF SCHIZOSACCHAROMYCES-POMBE, Molecular pharmacology, 50(5), 1996, pp. 1080-1086